Stem Cell Transplantation in 2020: A Workforce and Infrastructure Assessment

描述（由申请人提供）： 我们寻求NHLBI/NCI支持将于9月10日举行的会议（第二次专题讨论会）。14-15，2011年在芝加哥，这将解决造血干细胞劳动力和系统基础设施问题。SCI计划和3年一次的研讨会：造血干细胞移植（HSCT）是目前已知的唯一治疗许多危及生命的血液病患者的治疗方法。美国每年进行超过20，000例HSCT，预计到2020年对HSCT的需求将增加。HSCT增长面临的最大挑战是劳动力短缺和缺乏足够的基础设施，因此迫切需要解决这些问题。国家骨髓捐献者计划（NMDP）制定了一项为期3年的系统能力倡议计划（SCI），旨在与主要学术组织、专家和利益相关者合作，评估HSCT劳动力和系统基础设施问题。该SCI计划将评估并建议对影响HSCT使用的劳动力和基础设施挑战的补救措施，重要的是，少数群体和服务不足的患者群体获得护理。在SCI计划的三年结束时，每年将举行一次全国研讨会，讨论数据和提出的建议。在SCI计划的3年期间，指导委员会将协调七个工作组的活动：（1）医生劳动力，（2）护理劳动力，（3）高级实践专业人员劳动力，（4）药房劳动力，（5）设施/护理交付模式，（6）财务，（7）多样性和医疗差异。SCI计划的第一年计划和第一次研讨会于2009年秋季开始。工作组于2010年2月成立，并于3月至9月每月举行电话会议。各工作组于2010年9月15日至16日在芝加哥举行第一次专题讨论会。第一次专题讨论会严格审查了各工作组的优先建议。NMDP内部资助的第一年作为一个试点项目，以衡量HSCT社区对SCI的兴趣和热情。一个非常强烈的积极反应导致启动SCI系列的第二年和专题讨论会的需要。SCI计划第二年和第二次专题讨论会（本次资助申请的对象）将基于第一年工作组的工作成果和第一次专题讨论会的建议。我们计划调查策略，以增加HSCT劳动力的招聘和保留，并改善HSCT领域的医生，护士和其他医疗保健专业人员的工作生活平衡。分析将包括妇女、种族/少数民族、残疾人和其他在科学和研究生院代表性不足的个人的作用。我们将评估当前州和联邦立法对提供HSCT服务的影响;向医院管理者提供美国各地区HSCT人员配置和能力规范的数据;提高对最佳HSCT转诊指南的认识;传播移植各阶段护理人员支持和教育的最佳实践;制定供保险公司采用的移植福利模型;分析国家药剂师队伍的现状，以确保HSCT专业的肿瘤药剂师的代表性，以帮助满足预期的群体需求;并为设施/能力和护理提供模式工作组制定优先事项。SCI第二年将达到高潮，正如第一年一样，在一个国家研讨会-研讨会第二年。第二次专题讨论会将对7个工作组的产出进行评估、优先排序和审查，并向SCI所有其他工作组的成员介绍调查结果。HSCT倡议的系列研讨会的第三年将举行审查，起草，讨论和传播一套建议和指导方针。这一持续3年的倡议将为推动医疗保健政策的变革提供动力，并将使国家和地区利益攸关方能够充分代表。

DESCRIPTION (provided by applicant): We seek NHLBI/NCI support of a Conference (Symposium-II) to be held Sept. 14-15, 2011 in Chicago, that will address hematopoietic stem cell workforce and system infrastructure issues. SCI Program and 3 Yearly Symposia: Hematopoietic stem-cell transplantation (HSCT) is the only known curative therapy for many patients with life-threatening hematologic diseases. More than 20,000 HSCT are performed in the United States yearly and the need for HSCT is expected to increase by 2020. The biggest challenges to HSCT growth are workforce shortages and lack of adequate infrastructure, so a critical need exists to address these issues. The National Marrow Donor Program (NMDP) has developed a 3-year System Capacity Initiative Program (SCI) designed to evaluate HSCT workforce and system infrastructure issues in collaboration with key academic organizations, experts and stakeholders. This SCI Program will evaluate and recommend remedies to workforce and infrastructure challenges affecting HSCT use and importantly, access to care by minority and underserved patient populations. At the end of each of the three years of the SCI Program, a national Symposium will be held to address data and the recommendations that were developed. During the 3 years of the SCI Program, a Steering Committee will coordinate the activities of seven Working Groups: (1) Physician Workforce, (2) Nursing Workforce, (3) Advanced Practice Professionals Workforce, (4) Pharmacy Workforce, (5) Facilities/Care Delivery Model, (6) Financial, (7) Diversity and Health Care Disparities. Year 1 planning for the SCI Program and the first Symposium began in Fall 2009. Working groups were launched in February 2010 and held monthly conference calls from March to September. The working groups assembled in Chicago on September 15-16, 2010 for Symposium-I. This Symposium-I critically reviewed the working groups' prioritized recommendations. The NMDP internally funded Year 1 as a pilot project to gauge interest and enthusiasm for the SCI by the HSCT community. A very strong positive response led to initiating Year 2 of the SCI Series and the need for Symposium-II. Year 2 of the SCI Program and Symposium-II (the object of this grant request) will be based on outcomes of Year 1 working group efforts and recommendations from Symposium-I. We plan to investigate strategies to increase HSCT workforce recruitment and retention and improve work life balance for physicians, nurses and other health care professionals in the HSCT field. The analysis will include the role of women, racial/ethnic minorities, persons with disabilities, and other individuals underrepresented in science and graduate schools. We will assess the impact of current State and Federal Legislation on the delivery of HSCT services; make available to hospital administrators data on HSCT norms for staffing and capacity across regions of the U.S; raise awareness of optimal HSCT referral guidelines; disseminate best practices for caregiver support and education for all phases of transplant; develop model transplant benefits for insurers to adopt; analyze the current status of the national Pharmacy Workforce to ensure representation by oncologic pharmacists specializing in HSCT to help meet expected group needs; and develop priorities for Facilities/ Capacity and Care Delivery Model Working Groups. SCI Year 2 will culminate, as did Year 1, in a National Symposium- Symposium Year II. Symposium-II will evaluate, prioritize and review the output of the 7 working groups and present findings to members of all of the other SCI working groups. Year 3 of the Symposium Series of the HSCT initiative will be held to review, draft, discuss, and disseminate a set of Recommendations and Guidelines. This sustained 3-year initiative will provide momentum to drive change in health care policy and will allow adequate representation of national and regional stakeholders.